Students — get inspired at London Calling 2026! Discover cutting-edge science, hear from world-leading researchers, and explore Oxford Nanopore technology. Ignite your curiosity, fuel your ambition, and be part of the next generation of scientists. https://bit.ly/3MJtnIl
At #ACMGtg26, Tjakko van Ham will discuss implementing Oxford Nanopore sequencing in clinical genetics — including comprehensive variant calling & methylation analysis in unresolved rare disease, & ultra-rapid WGS from sample to variants in 24 hours. https://bit.ly/3OLC0CR
Wendy Chung has identified the genetic basis of ~60 rare diseases.
At #ACMGtg26, she’ll share how they characterised previously inaccessible regions of the genome – expanding the frontier of rare disease discovery. https://bit.ly/4rdk8OX
At AMP, Francisco Marchi presented the Acute Leukaemia Methylome Atlas, demonstrating how long Oxford Nanopore reads and machine learning could predict AML subtypes and outcomes with remarkable accuracy.
Watch his talk: https://bit.ly/3MPM0dB
What if an end to the diagnostic odyssey was in reach?
Join our symposium at #ACMGtg26 to hear from leading speakers who are moving closer to making this possible, using Oxford Nanopore sequencing to unlock multiomic insights. https://bit.ly/3MPyTcl
15% of hereditary diseases & cancers are tied to abnormal gene expression, yet most methods limit isoform resolution. Abi shares how direct RNA sequencing captures transcripts in full, exposing hidden biology & unlocking new disease insights.
Learn more: https://bit.ly/3ZKodyM
On #WWD2026, discover how ORG one is enabling local, equitable sequencing of endangered species — from spider monkeys to Asian king vultures — and building an open-access genome database to support global conservation. Learn more: https://bit.ly/3ZWB94z
For children with leukaemia, faster answers matter.
Marilyn Li (CHOP) is using real-time nanopore sequencing — with gold-standard direct methylation calling built in — to classify tumours in minutes.
Featured in GenomeWeb. Read here: https://bit.ly/4r2QhIJ?
For research use only.
20+ years without answers.
This #RareDiseaseDay, Emil Gustavsson visited our HQ to share how his team uncovered the cause of one form of spinocerebellar ataxia — finally bringing clarity after decades of uncertainty.
Learn more: https://bit.ly/4kWjR14
When your questions demand more, let multidimensional insights lead you to your next big discovery.
Ask more of your sequencing. https://bit.ly/3OvgodT #AGBTGM26
Transform your targeting sequencing assays on P2i with digital panels for on-device target selection, powered by Adaptive Sampling.
Learn more: https://bit.ly/4cKh09m #AGBTGM26
At #AGBTGM26, Lakmal Jayasinghe shared why nanopore sequencing is the gold standard for methylation calling, ushering a new era of discovery.
Building on that capability, Marilyn Li shared how combined genetic + epigenetic insights are reshaping oncology.
https://bit.ly/3ZWlP88
Join us at #nanoporeconf for a panel plenary exploring how epigenetics could unlock new answers in clinical research. From population-scale methylation research & real-time paediatric cancer profiling, to cell-type epigenetics.
Learn more: https://bit.ly/4kTYz4m
Watch on demand as Areeba Patel shares rapid, comprehensive molecular profiling of CNS tumours using methylation-based Oxford Nanopore sequencing, showcasing its potential for clinical implementation. https://bit.ly/4qHzpak
*Oxford Nanopore technology is for research use only
When you need a multiomic view to see the bigger picture, P2i is the fully integrated sequencer you can count on for greater insights into human health and disease. Ask more of your sequencing. https://bit.ly/4qSDXuA #AGBTGM26
When your questions demand more, let multidimensional insights lead you to your next big discovery.
Ask more of your sequencing. #AGBTGM26 https://bit.ly/4awT0VZ
📢 🧬 NEW GENOME ALERT
In #G3journal, Jaime Chaves and colleagues present genome assemblies of two rare bird species endemic to the Galápagos Islands by leveraging the @nanoporetech.com long-sequencing reads to generate real-time genetic data on site. (1/3) 🧵
We are now into our third phase of London Calling tickets. Find out more: https://nanoporetech.com/about/events/conferences/lc26?utm_campaign=London+Calling+26&utm_content=1771606324&utm_medium=social&utm_source=bluesky
Hear how researchers are using Oxford Nanopore sequencing to uncover variants missed by traditional methods.
Learn more: https://nanoporetech.com/applications/research-areas/clinical-research?utm_campaign=Human+rare+26&utm_content=1771504140&utm_medium=social&utm_source=bluesky
Learn more about adaptive sampling in our Nanopore Know-How: https://nanoporetech.com/blog/guided-by-data-adaptive-sampling-for-targeted-sequencing?utm_campaign=OmicsTech+25&utm_content=1771441621&utm_medium=social&utm_source=bluesky
In neonatal intensive care units, speed is vital.
Oxford Nanopore’s workflow delivers whole-genome sequencing in 24 hours, offering rapid variant insights that could transform clinical care — through faster answers & reduced costs.
Learn more: https://bit.ly/4rR9jCy
We are now into our third phase of London Calling tickets. Find out more: https://nanoporetech.com/about/events/conferences/lc26?utm_campaign=London+Calling+26&utm_content=1771265641&utm_medium=social&utm_source=bluesky
As one part of our many international collaborations, our team of the Biodiversity Genomics Center Cologne, BioC2 @unicologne.bsky.social, conducted a @nanoporetech.com workshop at the UNAM in Windhoek last week.
Big thanks to Tarja Hoffmeyer and Joseph Kirangwa for running this. Long-reads rule!
Learn more about adaptive sampling in our latest #Nanopore Know-How. Learn more here: https://nanoporetech.com/blog/guided-by-data-adaptive-sampling-for-targeted-sequencing?utm_campaign=Platform+%2F+Omics+26&utm_content=1770985380&utm_medium=social&utm_source=bluesky
Researchers detected a salmonellosis outbreak 5 weeks before food recall was triggered.
By combining wastewater sequencing with AI, researchers have shown how outbreaks could be spotted sooner, with the potential to save lives.
Find out more: https://bit.ly/4b8Dal8
Critically ill patients need rapid genomic diagnosis. Don’t miss Mark Drost at #AGBT where he’ll share how his team reached disease insights 3x faster than standard methods, with the potential to support more timely clinical decisions. https://bit.ly/4qlkIK5
EXCITING day in our Lab! SI HS Ss have been learning how to use @nanoporetech.com DNA sequencing technology We've tried & failed many times We just got our longest high quality read @ 73,000 bases! It's 100% coverage & 100% similarity to staphlococcus aureus! @nysmtp.bsky.social @dnalc.bsky.social
Announcing the #banana pangenome generated by @keygene.com using @nanoporetech.com long PromethION read platform. www.linkedin.com/posts/alexan...
You are correct; however, the paper was published in Nature last week.
Are we a step closer to safer blood transfusions? Using adaptive sampling, researchers demonstrate how more comprehensive nanopore data could transform donor-patient matching, reducing the risks of rejection. https://bit.ly/4qqbRr3
